1.2200
+0.1100
+(9.91%)
At close: April 17 at 4:00:00 PM EDT
1.1732
-0.05
(-3.84%)
After hours: April 17 at 6:52:46 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-9,490.5370
-9,490.5370
-7,695.2420
-5,468.0650
-1,600.1980
Investing Cash Flow
--
--
-5.9160
-1.6690
-18.1140
Financing Cash Flow
6,208.5080
6,208.5080
9,323.3540
2,153.2700
7,826.9380
End Cash Position
826.8480
826.8480
4,045.3810
2,700.7240
6,889.3290
Capital Expenditure
--
--
-5.9160
-1.6690
-6.9430
Issuance of Capital Stock
6,208.5080
6,208.5080
7,323.3540
--
230.0190
Issuance of Debt
--
--
2,000
--
7,593.3800
Repayment of Debt
--
--
--
--
-12.3310
Free Cash Flow
-9,490.5370
-9,490.5370
-7,701.1580
-5,469.7340
-1,607.1410
3/31/2021 - 5/17/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MLEC Moolec Science SA
0.6762
-6.08%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
603439.SS Guizhou Sanli Pharmaceutical Co.,Ltd
12.51
-0.40%
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%
MVR0.BE Medivir AB
0.1372
-2.42%
ICY.HA Incyte Corp
51.16
-0.31%
0M4.DU Mersana Therapeutics Inc
0.3157
+12.99%
DBV.F DBV Technologies S.A.
1.2520
+1.79%
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%